Key Record Dates
ClinicalTrials.gov Identifier: | NCT04489888 |
---|---|
Brief Title: | A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10) |
First Submitted : | July 27, 2020 |
First Submitted that Met QC Criteria : | July 27, 2020 |
First Posted : | July 28, 2020 |
Last Update Submitted that Met QC Criteria : | March 27, 2023 |
Last Update Posted : | March 29, 2023 |